Ameliorating Effect of Dietary Xylitol on Human Respiratory Syncytial Virus (hRSV) Infection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Xu, Mei Ling | - |
dc.contributor.author | Wi, Ga Ram | - |
dc.contributor.author | Kim, Hyoung Jin | - |
dc.contributor.author | Kim, Hong-Jin | - |
dc.date.available | 2019-03-08T13:01:00Z | - |
dc.date.issued | 2016-04 | - |
dc.identifier.issn | 0918-6158 | - |
dc.identifier.issn | 1347-5215 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/7082 | - |
dc.description.abstract | Human respiratory syncytial virus (hRSV) is the most common cause of bronchiolitis and pneumonia in infants. The lack of proper prophylactics and therapeutics for controlling hRSV infection has been of great concern worldwide. Xylitol is a well-known sugar substitute and its effect against bacteria in the oral cavity is well known. However, little is known of its effect on viral infections. In this study, the effect of dietary xylitol on hRSV infection was investigated in a mouse model for the first time. Mice received xylitol for 14d prior to virus challenge and for a further 3 d post challenge. Significantly larger reductions in lung virus titers were observed in the mice receiving xylitol than in the controls receiving phosphate-buffered saline (PBS). In addition, fewer CD3(+) and CD3(+)CD8(+) lymphocytes, whose numbers reflect inflammatory status, were recruited in the mice receiving xylitol. These results indicate that dietary xylitol can ameliorate hRSV infections and reduce inflammation-associated immune responses to hRSV infection. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.title | Ameliorating Effect of Dietary Xylitol on Human Respiratory Syncytial Virus (hRSV) Infection | - |
dc.type | Article | - |
dc.identifier.doi | 10.1248/bpb.b15-00773 | - |
dc.identifier.bibliographicCitation | BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.39, no.4, pp 540 - 546 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000373246100010 | - |
dc.identifier.scopusid | 2-s2.0-84994204640 | - |
dc.citation.endPage | 546 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 540 | - |
dc.citation.title | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.volume | 39 | - |
dc.type.docType | Article | - |
dc.publisher.location | 일본 | - |
dc.subject.keywordAuthor | human respiratory syncytial virus | - |
dc.subject.keywordAuthor | xylitol | - |
dc.subject.keywordAuthor | lung virus titer | - |
dc.subject.keywordAuthor | immune response | - |
dc.subject.keywordPlus | RED GINSENG EXTRACT | - |
dc.subject.keywordPlus | BRONCHOALVEOLAR LAVAGE | - |
dc.subject.keywordPlus | BALB/C MICE | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | BRONCHIOLITIS | - |
dc.subject.keywordPlus | INFLUENZA | - |
dc.subject.keywordPlus | RESPONSES | - |
dc.subject.keywordPlus | MOUSE | - |
dc.subject.keywordPlus | RIBAVIRIN | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.